Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/cei.13092 http://scihub22266oqcxt.onion/10.1111/cei.13092 C5842411!5842411!29266228     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Exp+Immunol 2018 ; 192 (1): 1-6 Nephropedia Template TP {{tp|p=29266228|t=2018. Therapeutic potential of phages in autoimmune liver diseases |pdf=|usr=}}{{29266228}} gab.com Text Therapeutic potential of phages in autoimmune liver diseases JO: Clin Exp Immunol http://www.kidney.de/pget.php?&tw=1&pmid=29266228 #FOAvip Autoimmune liver disease (ALD) poses a difficult medical challenge, as there is a significant number of patients in whom current therapy offers questionable or no benefit, yet its side effects may be serious, including the development of malignancy. Bacterial viruses (phages) have been recognized increasingly as immunomodulators contributing to immune homeostasis and curbing inflammation. Accumulating data suggest that phages may be useful in immunotherapy of ALD. Phages have been shown to down?regulate the expression and/or production and activity of factors associated with hepatic injury [reactive oxygen species, Toll?like receptor (TLR)?4 activation, nuclear factor kappa B (NF??B) activation, proinflammatory and procoagulant activities of platelets] and up?regulate the expression and/or production of factors demonstrated as playing a protective role [interleukin (IL)?10, IL?1 receptor antagonist]. Twit Text FOAVip Therapeutic potential of phages in autoimmune liver diseases ????Clin Exp Immunol http://www.kidney.de/pget.php?&tw=1&pmid=29266228 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29266228 #FOAvip English Wikipedia <ref>{{Cite pmid|29266228}}</ref> Therapeutic potential of phages in autoimmune liver diseases #MMPMID29266228 Górski A; Jo?czyk?Matysiak E; ?usiak?Szelachowska M; Weber?D?browska B; Mi?dzybrodzki R; Borysowski J Clin Exp Immunol 2018[Apr]; 192 (1): 1-6 PMID29266228show ga Autoimmune liver disease (ALD) poses a difficult medical challenge, as there is a significant number of patients in whom current therapy offers questionable or no benefit, yet its side effects may be serious, including the development of malignancy. Bacterial viruses (phages) have been recognized increasingly as immunomodulators contributing to immune homeostasis and curbing inflammation. Accumulating data suggest that phages may be useful in immunotherapy of ALD. Phages have been shown to down?regulate the expression and/or production and activity of factors associated with hepatic injury [reactive oxygen species, Toll?like receptor (TLR)?4 activation, nuclear factor kappa B (NF??B) activation, proinflammatory and procoagulant activities of platelets] and up?regulate the expression and/or production of factors demonstrated as playing a protective role [interleukin (IL)?10, IL?1 receptor antagonist]. äTherapeutic potential of phages in autoimmune liver diseases (epmc).pdf DeepDyve Pubget Overpricing